ZA7628B - Pharmaceutical preparation for the treatment of circulatory disorders - Google Patents

Pharmaceutical preparation for the treatment of circulatory disorders

Info

Publication number
ZA7628B
ZA7628B ZA00760028A ZA7628A ZA7628B ZA 7628 B ZA7628 B ZA 7628B ZA 00760028 A ZA00760028 A ZA 00760028A ZA 7628 A ZA7628 A ZA 7628A ZA 7628 B ZA7628 B ZA 7628B
Authority
ZA
South Africa
Prior art keywords
treatment
pharmaceutical preparation
circulatory disorders
circulatory
disorders
Prior art date
Application number
ZA00760028A
Other languages
English (en)
Inventor
P Imhof
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of ZA7628B publication Critical patent/ZA7628B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/625—Salicylic acid; Derivatives thereof having heterocyclic substituents, e.g. 4-salicycloylmorpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA00760028A 1975-01-06 1976-01-05 Pharmaceutical preparation for the treatment of circulatory disorders ZA7628B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH7175 1975-01-06

Publications (1)

Publication Number Publication Date
ZA7628B true ZA7628B (en) 1976-12-29

Family

ID=4178628

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA00760028A ZA7628B (en) 1975-01-06 1976-01-05 Pharmaceutical preparation for the treatment of circulatory disorders
ZA00760026A ZA7626B (en) 1975-01-06 1976-01-05 Pharmaceutical preparations for the treatment of coronary heart diseases

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA00760026A ZA7626B (en) 1975-01-06 1976-01-05 Pharmaceutical preparations for the treatment of coronary heart diseases

Country Status (14)

Country Link
JP (1) JPS5191337A (cs)
AU (1) AU499140B2 (cs)
BE (1) BE837293A (cs)
CA (1) CA1063516A (cs)
DE (1) DE2600069A1 (cs)
FR (1) FR2296430A1 (cs)
GB (1) GB1510370A (cs)
HK (1) HK49680A (cs)
IE (1) IE42766B1 (cs)
IL (1) IL48785A (cs)
MY (1) MY8100159A (cs)
NL (1) NL7600045A (cs)
NZ (1) NZ179623A (cs)
ZA (2) ZA7628B (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0019006A1 (de) * 1979-05-14 1980-11-26 Ciba-Geigy Ag Pharmazeutische Präparate, die als Wirkstoff ein substituiertes Pyrazolidinderivat enthalten, deren Verwendung und Verfahren zu ihrer Herstellung
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
TW284688B (cs) * 1991-11-20 1996-09-01 Takeda Pharm Industry Co Ltd
US5731339A (en) * 1995-04-28 1998-03-24 Zonagen, Inc. Methods and formulations for modulating the human sexual response

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL37700A (en) * 1970-10-02 1975-05-22 Ciba Geigy Ag Pharmaceutical preparations containing an aryloxypropanolamine derivative or an arylethanolamine derivative

Also Published As

Publication number Publication date
HK49680A (en) 1980-09-12
IE42766L (en) 1976-07-06
ZA7626B (en) 1976-12-29
JPS5191337A (cs) 1976-08-10
IL48785A0 (en) 1976-03-31
IL48785A (en) 1978-08-31
NL7600045A (nl) 1976-07-08
AU499140B2 (en) 1979-04-05
CA1063516A (en) 1979-10-02
AU1000276A (en) 1977-07-14
IE42766B1 (en) 1980-10-08
MY8100159A (en) 1981-12-31
BE837293A (fr) 1976-07-05
GB1510370A (en) 1978-05-10
FR2296430B1 (cs) 1978-11-10
FR2296430A1 (fr) 1976-07-30
NZ179623A (en) 1978-03-06
DE2600069A1 (de) 1976-07-15

Similar Documents

Publication Publication Date Title
IL50787A (en) Process for the preparation of corticoids
GB1547802A (en) Process for the preparation of poly-phenyleneterephthalamide
GB1517423A (en) Process for the preparation of diaryl-carbonates
PT65486A (en) Process for the preparation of carbonil-substituted 1-sulfonylbenzimidazoles
SE7601204L (sv) Terapeutiskt system for administrering av skopolamin transdermalt
GB1535291A (en) Process for the preparation of amoxycillin
PT65255A (en) Process for the preparation of 11-desoxy-16-aryloxy-delta-tetranorprostaglandins
CH608786A5 (en) Process for the preparation of acetoacetylarylamides
GB1534077A (en) Process for the preparation of 5-acetoacetylamino-benzimidazolone
IL49122A (en) L-pyroglutamyl-l-histidyl-3-alkyl-prolineamide processes for their preparation and therapeutic compositions containing the same
ZA744888B (en) Therapeutical composition for the treatment of mycobacterioses
ZA761825B (en) Preparation of therapeutic compounds
FR2310769A1 (fr) Medicament pour le traitement de l'alopecia seborrhoeica
ZA7628B (en) Pharmaceutical preparation for the treatment of circulatory disorders
IL48787A0 (en) Pharmaceutical preparations comprising phentolamine,for the treatment of circulatory disorders
GB1552658A (en) Process for the preparation of s substituted phosphorodichloridothiolates
ZA763081B (en) Pharmaceutical preparations for the treatment of hyperuricacidemia
PH14251A (en) Process for the treatment of patients suffering from drepanocytosis
GB1520330A (en) Process for the preparation of phospholene-1-oxides or su-lphides
FR2310770A1 (fr) Medicament pour le traitement de l'alopecia areata
PH13439A (en) Method of preparing solid pharmaceutical unit dosage form
NZ184623A (en) Pharmaceutical composition for treatment of billiary lithiasis
ZM13576A1 (en) Method for the treatment of sugar cane
PT65357A (en) Process for the preparation of gammapyrones
PT65176B (en) Process for the preparation of 6-aminomethylated 3-oxygenated cholest-5-enes